Reuters
AstraZeneca chases biosimilar Avastin drug with Japanese groupReutersLONDON AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin. Its new 50/50 joint venture with ...AstraZeneca Strikes Deal to Develop Version of Roche's Avastinswissinfo.chall 4 news articles »
Home /
mesothelioma /
mesothelioma law firm /
AstraZeneca chases biosimilar Avastin drug with Japanese group
Friday, July 24, 2015
AstraZeneca chases biosimilar Avastin drug with Japanese group
By
Unknown
On
8:01 AM
Subscribe to:
Post Comments (Atom)